Immune system activation
PSK and PSP activate dendritic cells, macrophages, and NK cells via Toll-like receptor and Dectin-1 signaling, enhancing both innate and adaptive immune responses.
Adjunct cancer support
PSK is an approved cancer adjunct therapy in Japan, used alongside conventional chemotherapy for gastric, colorectal, and lung cancers. Trials show improved survival rates and reduced immunosuppression from chemotherapy.
Gut microbiome support
Turkey tail acts as a prebiotic, selectively feeding Bifidobacterium and Lactobacillus species. Clinical study showed significant increases in beneficial bacteria and reduction in Clostridium after supplementation.
Antioxidant protection
Rich in phenolic compounds including quercetin and baicalein that scavenge free radicals and reduce oxidative stress markers in both healthy and immunocompromised individuals.
TLR-2 and Dectin-1 activation
Beta-glucans in PSK and PSP bind pattern recognition receptors on macrophages and dendritic cells, triggering NF-κB activation and cytokine production that primes adaptive immune responses.
NK and T-cell augmentation
Turkey tail polysaccharides increase NK cell cytotoxicity and CD8+ T-cell activity, enhancing immune surveillance for abnormal or virus-infected cells.
Prebiotic fermentation
Polysaccharides from turkey tail are fermented by colonic microbiota, producing short-chain fatty acids and selectively feeding beneficial bacterial species, improving gut microbiome composition.
Open-label clinical study of turkey tail powder (2.4–4.8 g/day) for 8 weeks in healthy adults.
24 healthy adults. 8-week supplementation.
Dose-dependent increases in Bifidobacterium and Lactobacillus. Significant decreases in Clostridium and Staphylococcus. Improved microbiome diversity scores.
Meta-analysis of RCTs using PSK alongside chemotherapy in gastric cancer patients in Japan.
Multiple trials, hundreds of patients.
PSK supplementation significantly improved 5-year survival rates and reduced immunosuppression from chemotherapy. Now standard-of-care adjuvant in Japan for GI cancers.